Skip to content

Mechanisms and Interventions of Psycho-Sleep-Cognitive Interactions in Aging, and Cohort Study on Pre-Dementia Sleep-Psychological Changes

Mechanisms and Interventions of Psycho-Sleep-Cognitive Interactions in Aging, and Cohort Study on Pre-Dementia Sleep-Psychological Changes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124866
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Behavioral Impairment (MBI)

Interventions

Psychological-Sleep-Cognitive Impairment Observation Group:None

Sponsors

Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for the multi-center cohort: 1. Multi-center cohort of sleep disorders: Elderly individuals who have been included in the Shanghai SHAPE community and clinical cohort, and the Shandong MIND rural cohort. The baseline data is complete and they meet the diagnostic criteria for any type of sleep and wake disorder according to ICD-11. The patients have signed the informed consent form. 2. Multi-center cohort of healthy controls: Elderly individuals who have been included in the Shanghai SHAPE community and clinical cohort, and the Shandong MIND rural cohort. The baseline data is complete and they do not meet the diagnostic criteria for any type of sleep and wake disorder according to ICD-11. The patients have signed the informed consent form. (Shanghai SHAPE community and clinical cohort inclusion criteria: Age >= 60 years old, residing in Shanghai, the patients or their legal guardians have signed the informed consent form, and there is no severe visual impairment. Shandong MIND rural cohort inclusion criteria: Age >= 60 years old, all registered residents of 52 villages in Yanggu County, no severe mental illness.) 3. Sub-cohort inclusion criteria: Genomic inclusion criteria: Meet the inclusion criteria for the "multi-center cohort of sleep disorders" mentioned above; agree to provide 5 milliliters of blood or 10 milliliters of cerebrospinal fluid samples for genomic sequencing and analysis; Brain network group inclusion criteria: Meet the inclusion criteria for the "genomic" mentioned above: agree to undergo brain magnetoencephalography and multimodal head magnetic resonance imaging examinations. 4. APOE4 carrying cohort inclusion criteria: Community elderly or outpatients of Shanghai Mental Health Center; Age >= 60 years old, gender not limited; at least 5 years of education; 1 or 2 APOE4 gene carriers; the patients or their legal guardians have signed the informed consent form.

Exclusion criteria

Exclusion criteria: Multicenter cohort exclusion criteria: 1. Exclude patients with severe physical diseases, those with suicidal attempts; within the past month, history of stroke, cerebrovascular accident, epilepsy, or cranial trauma; after SCID interview, exclude other Axis I mental disorders except dementia, including: schizophrenia, affective mental disorders, anxiety spectrum disorders; the researcher considers there are other situations that make them unsuitable to participate in this clinical trial. Genomic exclusion criteria: The same as the 4 items in the "multicenter cohort exclusion criteria"; have a clearly diagnosed genetic genetic disease. Brain network group exclusion criteria: The same as the 5 items in the "genomic exclusion criteria"; have magnetic metal implants in the body; have claustrophobia and cannot complete magnetic resonance examination. 2. APOE4 carrier cohort exclusion criteria Exclude patients with severe physical diseases, those with suicidal attempts; within the past month, history of stroke, cerebrovascular accident, epilepsy, or cranial trauma; after SCID interview, exclude other Axis I mental disorders except dementia, including: schizophrenia, affective mental disorders, anxiety spectrum disorders; the researcher considers there are other situations that make them unsuitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary Coupling (CPC);

Secondary

MeasureTime frame
Magnetoencephalography (MEG);Multimodal Magnetic Resonance Imaging (Multimodal MRI);Dense-array Electroencephalography (dEEG);Cranial PET-CT;

Countries

China

Contacts

Public ContactLi Xia

Shanghai Mental Health Center

lixia11111@sjtu.edu.cn+86 180 1731 1175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026